Oncotarget is a peer-reviewed medical journal founded in 2010. Oncotarget is published on a weekly basis by Impact Journals and covers oncology research. Most importantly, Oncotarget focuses on research involving treatments and protocols deployed to enhance the well-being of cancer patients, potential therapy targets, as well as the clinical basis of all strains of cancer.
Oncotarget adheres to the principles of COPE (Committee on Publication Ethics) and is a member of the body. The impact publication project seeks to define the healthcare professionals and patient acceptance of new as well as existing drugs, treatment methods, and available forms of therapy. Oncotarget tries to improve the lives of cancer patients and to improve the outcomes of these procedures by discovering new information.
Oncotarget places emphasis on patient perspectives vis-à-vis satisfaction, adherence, and their quality of life. They employ certain treatment protocols, existing therapeutic agents, as well as the impact of management programs on the lives of patients. The journal’s recent success on the oncology front has led to the exploration of other medical fields.
According to Research Gate, Oncotarget is dedicated to the attainment of a world without disease under the leadership of a group of elite researchers and scientists from the world over.
The journal advocates for the use of basic clinical science to eradicate disease and break boundaries within medical specialties towards quicker discoveries and make scientific research widely and rapidly available.
On E-cigarettes and Alleged Damage to Gum Tissue
A recent survey on the effects of e-cigarettes financed by National Institutes of Health was published on Oncotarget. The research, which was conducted under the leadership of UR’s Department of Environmental Medicine professor Irfan Rahman (Ph.D.), was the first ever on the subject on molecular and cellular levels.
E-cigarettes are known to be the safer option, popular among people struggling to quit smoking and the younger generation. However, this particular study shows that e-cigarettes can cause multiple oral infections and cell damage.
The problem with e-cigarettes according to the study is the flavoring which damages the gums. The lead scientists urged manufacturers to disclose all the compounds used to manufacture the flavors so that more research can be carried out on the effects of e-cigarettes.
Apart from this specific study, a growing body of scientific data suggests that the chemicals found in e-cigarettes have the potential effects of adverse health conditions associated with convention smokes. Professor Rahman also published another study with similar findings on pollution and health effects of e-cigarettes in late 2015.